ArticleFrontiers in oncology2022

Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency.

Jing Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.